31 results
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... 3 years • Co-testing ... HumanPapillomavirus #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... and Treating Penicillium ... Penicilliosis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Preventing ... Enteric #Bacterial #IDSA ... infections #HIVAIDS #pharmacology
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
susceptibility testing ... #IDSA #Meningitis ... InfectiousDiseases #Pharmacology
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for Preventing ... and Treating Chagas ... Trypanosomiasis #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... and Treating Toxoplasma ... #Encephalitis #IDSA ... #pharmacology
Group A Strep Pharyngitis, also known as  Strep Throat. 

In addition to symptomatic presentation, a
antigen detection test ... retail/community setting ... recommended by IDSA ... That's because this test ... penicillin allergy testing
Helicobacter Pylori Testing  Methods - Sensitivity and Specificity

Serology - 85% - 79% - Does not
Helicobacter Pylori Testing ... other means of testing ... Urea breath test ... first line test ... or unexplained IDA
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for Treating Mucosal ... candida #mucosal #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... for Treating Visceral ... every 21 days Treating ... Leishmaniasis #Prevention ... infections #HIVAIDS #pharmacology